Larvol Delta - A-Phase-IbII-Clinical-Study-of-Camrelizumab-and-Apatinib-Plus-GP-in-the-Treatment-of-Advanced-Biliary-Tract-Cancer

AiTan (rivoceranib) - Elevar Therapeutics

gemcitabine - Generic mfg.

cisplatin - Generic mfg.

AiRuiKa (camrelizumab) - Elevar Therapeutics

http://clinicaltrials.gov/ct2/show/NCT05742750

Jun 13, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next